- $2.84bn
- $3.53bn
- $1.10bn
- 62
- 36
- 90
- 68
Annual income statement for Acuren, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 928 | 1,050 | 1,097 |
| Cost of Revenue | |||
| Gross Profit | 203 | 240 | 266 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 881 | 996 | 1,154 |
| Operating Profit | 47.2 | 54.5 | -56.3 |
| Total Net Non Operating Interest Income / Expense | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 23.5 | -4.28 | -123 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 20 | -6.29 | -121 |
| Net Income Before Extraordinary Items | |||
| Net Income | 20 | -6.29 | -121 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 20 | -6.29 | -121 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 0.173 | -0.117 | -0.723 |
| Dividends per Share |